| Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales … PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy Clinical Infectious Diseases 72 (7), e169-e183, 2021 | 578 | 2021 |
| Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections PD Tamma, EL Heil, JA Justo, AJ Mathers, MJ Satlin, RA Bonomo Clinical infectious diseases, ciae403, 2024 | 555 | 2024 |
| Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and … PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy Clinical infectious diseases 74 (12), 2089-2114, 2022 | 498 | 2022 |
| Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant … PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D Van Duin, CJ Clancy Clinical Infectious Diseases 75 (2), 187-212, 2022 | 395 | 2022 |
| Infectious Diseases Society of America antimicrobial resistant treatment guidance: gram-negative bacterial infections PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D van Duin, CJ Clancy practice 6 (8), 2020 | 170 | 2020 |
| Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa JM Munita, SL Aitken, WR Miller, F Perez, R Rosa, LA Shimose, ... Clinical Infectious Diseases 65 (1), 158-161, 2017 | 148 | 2017 |
| Antifungal resistance: a concerning trend for the present and future JA Hendrickson, C Hu, SL Aitken, N Beyda Current infectious disease reports 21, 1-8, 2019 | 134 | 2019 |
| Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients F Foolad, SL Aitken, TL Shigle, A Prayag, S Ghantoji, E Ariza-Heredia, ... Clinical Infectious Diseases 68 (10), 1641-1649, 2019 | 118 | 2019 |
| American Society for Transplantation and Cellular Therapy series:# 3—prevention of cytomegalovirus infection and disease after hematopoietic cell transplantation M Hakki, SL Aitken, L Danziger-Isakov, MG Michaels, PA Carpenter, ... Transplantation and Cellular Therapy 27 (9), 707-719, 2021 | 90 | 2021 |
| Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study DN Shah, SL Aitken, LF Barragan, S Bozorgui, S Goddu, ME Navarro, ... Journal of Hospital Infection 93 (3), 286-289, 2016 | 86 | 2016 |
| Real-life assessment of the safety and effectiveness of the new tablet and intravenous formulations of posaconazole in the prophylaxis of invasive fungal infections via … FP Tverdek, ST Heo, SL Aitken, B Granwehr, DP Kontoyiannis Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00188-17, 2017 | 85 | 2017 |
| Successful treatment of bloodstream infection due to metallo-β-lactamase-producing Stenotrophomonas maltophilia in a renal transplant patient MF Mojica, CP Ouellette, A Leber, MB Becknell, MI Ardura, F Perez, ... Antimicrobial agents and chemotherapy 60 (9), 5130-5134, 2016 | 79 | 2016 |
| Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia SL Aitken, J Altshuler, DJ Guervil, EB Hirsch, LL Ostrosky-Zeichner, ... International journal of antimicrobial agents 45 (5), 541-544, 2015 | 74 | 2015 |
| Refractory and resistant cytomegalovirus after hematopoietic cell transplant in the letermovir primary prophylaxis era J Sassine, F Khawaja, TL Shigle, V Handy, F Foolad, SL Aitken, Y Jiang, ... Clinical Infectious Diseases 73 (8), 1346-1354, 2021 | 73 | 2021 |
| Whole-genome sequencing accurately identifies resistance to extended-spectrum β-lactams for major gram-negative bacterial pathogens SA Shelburne, J Kim, JM Munita, P Sahasrabhojane, RK Shields, ... Clinical Infectious Diseases 65 (5), 738-745, 2017 | 73 | 2017 |
| High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream … SL Aitken, JJ Tarrand, LM Deshpande, FP Tverdek, AL Jones, ... Clinical Infectious Diseases 63 (7), 954-958, 2016 | 73 | 2016 |
| Precision pharmacotherapy: integrating pharmacogenomics into clinical pharmacy practice JK Hicks, CL Aquilante, HM Dunnenberger, RS Gammal, RS Funk, ... Journal of the American College of Clinical Pharmacy 2 (3), 303-313, 2019 | 71 | 2019 |
| Aerosolized ribavirin: the most expensive drug for pneumonia RF Chemaly, SL Aitken, CR Wolfe, R Jain, MJ Boeckh Transplant Infectious Disease 18 (4), 634-636, 2016 | 66 | 2016 |
| Development and validation of a Clostridium difficile health-related quality-of-life questionnaire KW Garey, SL Aitken, L Gschwind, S Goddu, Y Xie, C Duff, F Barbut, ... Journal of clinical gastroenterology 50 (8), 631-637, 2016 | 63 | 2016 |
| Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics SL Aitken, ND Beyda, DN Shah, HR Palmer, TM Lasco, H Koo, KW Garey Annals of Pharmacotherapy 48 (6), 683-690, 2014 | 53 | 2014 |
Kevin GareyUniversity of Houstonuh.edu üzerinde doğrulanmış e-posta adresine sahip